Biosite(R) Incorporated to Conduct Investor Conference Call Following European Stroke Conference Symposium

Biosite(R) Incorporated to Conduct Investor Conference Call
Following European Stroke Conference Symposium 


SAN DIEGO, May 19  /PRNewswire-FirstCall/ -- Biosite Incorporated (NASDAQ:BSTE)
announces the following webcast:

   What:       Biosite Incorporated will conduct an investor conference call
               following the symposium, "A New Paradigm in Emergency Stroke
               Diagnosis," on May 27, 2005 at the 14th Annual European
               Stroke Conference in Bologna, Italy.  Featured in the
               teleconference will be Kim Blickenstaff, chairman and chief
               executive officer, and Ken Buechler, Ph.D., president and
               chief scientific officer, as well as Dr. Daniel Laskowitz,
               Duke University Medical Center; Dr. Philip Bath, University
               of Nottingham, United Kingdom; Dr. Edward Jauch, University
               of Cincinnati College of Medicine and Dr. Marco Fiorelli,
               University Hospital La Sapienza, Rome, Italy.

   When:       The conference call will take place Friday, May 27, 2005 at
               8:30 p.m. (local), or 2:30 p.m. Eastern Daylight Time, and
               will be webcast through Biosite's website at
http://www.biosite.com/.

   Where:
         http://phx.corporate-ir.net/playerlink.zhtml?c=69046&s=wm&e=1068523
         OR http://www.biosite.com/

   How:        Live over the Internet -- Simply log onto the web at the
               address above.

   Telephonic: Dial in #: [phone], International dial in #:
               [phone]
               Conference ID# 64535537.



If you are unable to participate during the live webcast, the call will be
archived on the Biosite web site http://www.biosite.com/ until June 17, 2005.

  Company press releases may be found at http://www.biosite.com/

  About Biosite Incorporated


Biosite Incorporated is a leading bio-medical company commercializing
proteomics discoveries for the advancement of medical diagnosis.  The Company's
products contribute to improvements in medical care by aiding physicians in the
diagnosis of critical diseases and health conditions. Biosite's Triage(R) rapid
diagnostics are used in approximately 50 percent of U.S. hospitals and in over
50 international markets.  Information on Biosite can be found at
http://www.biosite.com/.

(Minimum Requirements to listen to broadcast: The Windows Media Player
software, downloadable free from:
http://www.microsoft.com/windows/windowsmedia/mp10/default.aspx and at least a
28.8Kbps connection to the Internet.) 

DATASOURCE: Biosite Incorporated



CONTACT:  Simona Dixon, Corporate and Investor Relations of Biosite

Incorporated, [phone], ext. 3221, 



Web site:  http://www.biosite.com/ 



Company News On-Call:  http://www.prnewswire.com/comp/116737.html 

Copyright